Our Group
Together to help save more lives
Accomplishing our goal requires a collective effort.
Laerdal, a family-owned business, is not just one company, but a group of diverse companies all dedicated to our goal of helping save one million more lives, every year, by 2030.
Our different operations cover:
- Product and solutions.
- Financial mission.
- Financial investment.
Product and solution tools
To reach our One Million Lives goal, we develop technologies focused on two things: advancing simulation-based training and improving quality in treatment and care.
Laerdal Medical
A world leader for simulation-based medical education and resuscitation training as well as medical devices. Our solutions are used by voluntary organizations, educational institutions, hospitals, and the military worldwide.
Laerdal Global Health
A not-for-profit company focused on helping save lives at birth and from time-critical emergencies in low-resource settings. Collaborating with global and national partners, our solutions are integrated into scalable and sustainable programs.
Financial mission tools
To further our reach, we have several organizations that fund initiatives capable, or having the potential, to save lives at scale:
Laerdal Foundation
A research foundation, supporting practically oriented research to prevent needless deaths from sudden cardiac arrest, trauma, and during birth, having funded close to 2000 research projects with over 40 million USD.
Laerdal Million Lives Fund
An early-stage venture capital fund investing in entrepreneurs who are developing innovative and disruptive healthcare technology solutions capable of addressing the world's largest mortality and life-saving challenges.
Laerdal Scale Up Fund
A development fund, backed by a USD 100 million commitment by the Laerdal family, to support the expansion of proven programs addressing time-critical emergencies, turning early success into population-level impact.
Financial investment tools
Our goal also requires commercial asset management which is overseen by our investment equity ventures:
Laerdal Invest
A portfolio management company overseeing a diverse selection of equity, bonds, and private funds providing long-term capital management in support of the group's activities.
Laerdal Eiendom
A real estate management firm coordinating the various, Laerdal properties located in and around Stavanger, Norway with a focus on implementing sustainable solutions and neighborhood regeneration.
Case study: NeoBeat - How it all works together
In 2012, Laerdal Foundation funded a research project for Safer Births, investigating cardio respiratory transition at birth. The PhD endeavor sought to develop tools for guiding medical staff in treating asphyxiated newborns without adding clinical burden.
Our Strategic Research team joined the study and pursued further research in collaboration with our partner facilities leading to the development of NeoBeat.
In 2018, NeoBeat Heart Rate Monitor was first launched into Tanzania via Laerdal Global Health.
This pathway spurred an area of opportunity recognition by Laerdal Million Lives Fund. As NeoBeat continued to collect more data, there were insights that informed investment decisions moving forward.
After receiving CE certification under the EU MDR, NeoBeat was introduced to a wider audience on Laerdal Medical.
Additionally, NeoBeat is a part of the Safer Births Bundle of Care, one of the initiatives being funded for further outreach by the Laerdal Scale up Fund.
Other affiliates which advance our mission
Our partners around the world
The effect of what we do is a reflection of the strength of collaborating with others.
Outside of our entities, we work together with a wide-ranging collection of organizations, companies, and regulatory bodies to further our mission.
Mission Partners
Strategic alliances with regulatory bodies, NGOs, and other advocacy agencies enhancing our approach to drive our mission forward
Research Partners
Hospitals, healthcare centers, and medical laboratories for conducting research and collaborative projects for medical breakthroughs and/or PhD research.
Corporate Partners
Commercial entities with which we co-develop or license products and solutions as well as institutions with which we capitalize on investment opportunities